Chair, Department of Medicine
Mount Sinai Beth Israel
Professor of Medicine and Vice-Chair, Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York
Ira M. Jacobson, MD, has disclosed that that he has served as a consultant or on advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Intercept, Janssen, Merck, and Trek; has served on speaker bureaus for AbbVie, Gilead Sciences, Intercept and Merck; and has received funds for research support from AbbVie, Gilead Sciences, Genfit, and Merck.
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Stefan Zeuzem, MD, has disclosed that he has served as a consultant or on advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Roche.
Editorial Director, Virology & Other Therapeutic Areas
This program is intended for physicians including infectious diseases specialists, hepatologists, and gastroenterologists, registered nurses, and other healthcare professionals involved in the care of patients with liver disease.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 contact hour may be earned for successful completion of this activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 01, 2017, through January 31, 2018:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.
Expert HBV management review, including treatment candidacy, preferred treatment options, and antiviral resistance and advanced liver disease management.
When and how to treat hepatitis B infection in women of childbearing age, in early pregnancy, and in late pregnancy.
Expert blog from Dr. Zobair M. Younossi offering perspective on new HCV and NAFLD/NASH data from the 2018 EASL International Liver Congress in Paris.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.